HIMCH
MYGN icon

Hartford Investment Management Co (HIMCO)’s Myriad Genetics MYGN Stock Holding History

Hartford Investment Management Co (HIMCO)’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-11,828
Closed -$344K – 620
2018
Q4 		$344K Buy
11,828
+4,900
+71% +$176K 0.01% 553
2018
Q3 		$319K Sell
6,928
-462
-6% -$20.5K 0.01% 589
2018
Q2 		$276K Buy
+7,390
New +$250K 0.01% 639
2017
Q4 		– Sell
-9,190
Closed -$332K – 600
2017
Q3 		$332K Sell
9,190
-800
-8% -$22.8K 0.01% 558
2017
Q2 		$258K Buy
+9,990
New +$212K 0.01% 561

Other funds holding MYGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hartford Investment Management Co (HIMCO)'s MYGN Position: Q1 2019 in Review

Hartford Investment Management Co (HIMCO) sold out of Myriad Genetics (MYGN) in Q1 2019, closing a stake of 11,828 shares — an estimated $344K sold.

Hartford Investment Management Co (HIMCO) first reported a position in MYGN in Q2 2017 and held it in 5 quarters. The position peaked at $344K in Q4 2018. 262 funds tracked by Wall St. Rank hold MYGN as of Q1 2019.

  • Hartford Investment Management Co (HIMCO) reported no remaining Myriad Genetics position as of Q1 2019 after selling out during the quarter.
  • Hartford Investment Management Co (HIMCO) sold 11,828 Myriad Genetics shares in Q1 2019, an estimated $344K.
  • Hartford Investment Management Co (HIMCO) first reported a position in Myriad Genetics in Q2 2017 and held it in 5 quarters.
  • Hartford Investment Management Co (HIMCO)'s Myriad Genetics position peaked at $344K in Q4 2018.
  • 262 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2019.

Based on Hartford Investment Management Co (HIMCO)'s 13F filing for Q1 2019, filed 29 Apr 2019.